TRxADE Health Inc expected to post a loss of 11  cents a share - Earnings Preview

Scienture Holdings

22/04/2022 22:21

* TRxADE Health Inc  MEDS.OQ   MEDS.O  is expected to show a
fall
in quarterly revenue when it reports  results on April 25
(estimated). 
    * The Land O' Lakes Florida-based  company is expected to
report 
a 27.7% decrease in revenue to $2.208 million from $3.05 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for TRxADE Health Inc
is for
a loss of 11 cents per share. For the same quarter last year,
the company reported a loss of 8 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for TRxADE
Health Inc
is $6.25​, above​ its last closing price of $1.89. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.16       -0.15      -0.10     Beat    33.3
 Sep. 30 2021  -0.13       -0.13      -0.16     Missed  -23.1
 Jun. 30 2021  -0.09       -0.09      -0.17     Missed  -96.1​
 Mar. 31 2021  -0.05       -0.05      -0.08     Missed  -71.4
 ​​Dec.        0.01        0.01       -0.20     Missed  -2,100
 31 2020                                                
 Sep. 30 2020  0.03        0.03       0.02      Missed  -33.3​
 Jun. 30 2020  0.01        0.01       -0.07     Missed  -800
 Mar. 31 2020  0.01        0.01       0.02      Beat    100
 This summary was machine generated April 22 at 21:21 GMT.  All
figures in US dollars  unless otherwise stated